Quiz week 3 study set pharmacology
A phosphodiesterase-4 inhibitor that prevents coughing and excess mucus to improve
breathing – answer Roflumilast
A leukotriene receptor antagonist that decreases inflammatory response to improve
breathing. - answer Montelukast
an inhaled corticosteroid that decreases inflammatory response to improve breathing. -
answer Fluticasone
cause inflammation, bronchoconstriction, and mucus production – answer Leukotrienes
One of the major advantages of montelukast is it's approval for children over
________________ of age. - answer1 year
drugs that work by preventing the release of mediators that lead to allergic responses
that lead to constriction of airways and shortness of breath. They are given for
preventive purposes and should not be used as a rescue medication. Additionally, they
should be given in conjunction with other asthma treatments and not meant to be a
single drug therapy - answerMonoclonal antibody anti-asthmatic (MAA)
an enzyme that is mainly present in immune, epithelial and brain cells that modulates
inflammation and epithelial integrity. Thus, inhibiting this enzyme results in decreased
mucus production, decreased cough, and improved symptoms. This group of drugs is
primarily used in COPD to prevent or control exacerbations. It is not intended to treat
acute bronchospasms. Since this enzyme is present in brain cells, side effects can
include risk for psychiatric adverse effects - answerPhosphodiesterase type 4 (PDE4)
The major advantage to using _________________________________ over systemic
corticosteroids is the action occurring more topically within the lungs themselves.
However, there is still some systemic effect - answerinhaled corticosteroids
a LTRA and work to block leukotriene receptors to dampen the immune response. One
of the major advantages of montelukast is its approval for children over 1 year of age.
Additionally, it has fewer adverse effects and drug interactions than zafirlukast -
answerMontelukast (Singulair)
Leukotriene Receptor Antagonists, Inhaled Corticosteroids, Phosphodiesterase-4
Inhibitors, Monoclonal Antibody Antiasthmatics are all
__________________________________. - answernonbronchodilators
, beclomethasone, dexamethasone, flunisolide, triamcinolone are all
________________________________. - answerCorticosteroids
Corticosteroids are known as _______________________ and can occur naturally or
synthetically in drug form to treat respiratory conditions. They produce an anti-
inflammatory effect. - answerglucocorticoids
Corticosteroids can be given by several routes such as - answerinhalation, oral, and
intravenously
The major advantage to using __________________ corticosteroids over systemic
corticosteroids is the action occurring more topically within the lungs themselves. -
answerinhaled
a steroid medication found in nasal sprays and creams for topical use. -
answerTriamcinalone
a steroid/antibiotic eyedrop medication. - answerBelphamide
are primarily used in COPD to prevent or control exacerbations. They are not intended
to treat acute bronchospasms, cough caused by seasonal allergies, or asthma -
answerPhosphodiesterase-4 inhibitors
a leukotriene receptor antagonists (LTRAs). Montelukast should be reserved for use in
adults and children who cannot be treated with other medications for seasonal or annual
allergic rhinitis (inflammation of the mucous membrane of the nose - answerMontelukast
an add-on medication to other treatment regimens and not a primary treatment plan. -
answerLeukotriene receptor agonists (LTRAs)
____________________________________ is used for prevention and treatment of
respiratory issues in both adults in children. It is important to note that it is not a rescue
medication for acute attacks. The age at which montelukast can be used in children
varies depending on the condition for which it is being used.
Prevention
asthma attacks in adults and children as young as 12 months old
exercise-induced bronchoconstriction (narrowing of the air passages in the lungs) in
adults and children who are at least 6 years old
Treatment
symptoms of year-round allergies in adults and children who are at least 6 months old
symptoms of seasonal allergies in adults and children who are at least 2 years old. -
answerMontelukast
___________________________________ are chemicals your body releases from
leukocytes when you breathe in an allergen (such as pollen). Leukotrienes cause
A phosphodiesterase-4 inhibitor that prevents coughing and excess mucus to improve
breathing – answer Roflumilast
A leukotriene receptor antagonist that decreases inflammatory response to improve
breathing. - answer Montelukast
an inhaled corticosteroid that decreases inflammatory response to improve breathing. -
answer Fluticasone
cause inflammation, bronchoconstriction, and mucus production – answer Leukotrienes
One of the major advantages of montelukast is it's approval for children over
________________ of age. - answer1 year
drugs that work by preventing the release of mediators that lead to allergic responses
that lead to constriction of airways and shortness of breath. They are given for
preventive purposes and should not be used as a rescue medication. Additionally, they
should be given in conjunction with other asthma treatments and not meant to be a
single drug therapy - answerMonoclonal antibody anti-asthmatic (MAA)
an enzyme that is mainly present in immune, epithelial and brain cells that modulates
inflammation and epithelial integrity. Thus, inhibiting this enzyme results in decreased
mucus production, decreased cough, and improved symptoms. This group of drugs is
primarily used in COPD to prevent or control exacerbations. It is not intended to treat
acute bronchospasms. Since this enzyme is present in brain cells, side effects can
include risk for psychiatric adverse effects - answerPhosphodiesterase type 4 (PDE4)
The major advantage to using _________________________________ over systemic
corticosteroids is the action occurring more topically within the lungs themselves.
However, there is still some systemic effect - answerinhaled corticosteroids
a LTRA and work to block leukotriene receptors to dampen the immune response. One
of the major advantages of montelukast is its approval for children over 1 year of age.
Additionally, it has fewer adverse effects and drug interactions than zafirlukast -
answerMontelukast (Singulair)
Leukotriene Receptor Antagonists, Inhaled Corticosteroids, Phosphodiesterase-4
Inhibitors, Monoclonal Antibody Antiasthmatics are all
__________________________________. - answernonbronchodilators
, beclomethasone, dexamethasone, flunisolide, triamcinolone are all
________________________________. - answerCorticosteroids
Corticosteroids are known as _______________________ and can occur naturally or
synthetically in drug form to treat respiratory conditions. They produce an anti-
inflammatory effect. - answerglucocorticoids
Corticosteroids can be given by several routes such as - answerinhalation, oral, and
intravenously
The major advantage to using __________________ corticosteroids over systemic
corticosteroids is the action occurring more topically within the lungs themselves. -
answerinhaled
a steroid medication found in nasal sprays and creams for topical use. -
answerTriamcinalone
a steroid/antibiotic eyedrop medication. - answerBelphamide
are primarily used in COPD to prevent or control exacerbations. They are not intended
to treat acute bronchospasms, cough caused by seasonal allergies, or asthma -
answerPhosphodiesterase-4 inhibitors
a leukotriene receptor antagonists (LTRAs). Montelukast should be reserved for use in
adults and children who cannot be treated with other medications for seasonal or annual
allergic rhinitis (inflammation of the mucous membrane of the nose - answerMontelukast
an add-on medication to other treatment regimens and not a primary treatment plan. -
answerLeukotriene receptor agonists (LTRAs)
____________________________________ is used for prevention and treatment of
respiratory issues in both adults in children. It is important to note that it is not a rescue
medication for acute attacks. The age at which montelukast can be used in children
varies depending on the condition for which it is being used.
Prevention
asthma attacks in adults and children as young as 12 months old
exercise-induced bronchoconstriction (narrowing of the air passages in the lungs) in
adults and children who are at least 6 years old
Treatment
symptoms of year-round allergies in adults and children who are at least 6 months old
symptoms of seasonal allergies in adults and children who are at least 2 years old. -
answerMontelukast
___________________________________ are chemicals your body releases from
leukocytes when you breathe in an allergen (such as pollen). Leukotrienes cause
